Your search for Warfarin returned 250 results

No differences seen in fracture risk in head-to-head comparisons of direct oral anticoagulants

Morning or evening administration makes no difference on time outside target INR range.

Noninferiority not found compared with standard-intensity prophylaxis with hip or knee arthroplasty

The patient in this case had been well-controlled on warfarin therapy for over 5 years following mitral valve replacement.

Results from a new real-world study evaluating rivaroxaban (Xarelto; Janssen), a factor Xa inhibitor, in morbidly obese patients were recently published in Thrombosis Research. The retrospective cohort study analyzed data from 2 US claims databases (Truven MarketScan Commercial Claims and Encounters database and MarketScan Medicare Supplemental database) to evaluate the clinical and health/economic outcomes of…

“The elevation in INR can be explained by the inhibition of CYP2C9 by cannabis use causing decreased metabolism of warfarin,” the authors explained.

Findings seen in warfarin-treated patients with history of international normalized ratio instability

To investigate an appropriate dosing strategy for 4F-PCC (Kcentra; CSL Behring) in obese patients, the authors conducted a retrospective analysis comparing the reversal of warfarin using adjusted (N=28) vs actual body weight (N=50).

Compared with warfarin, apixaban was correlated with reduced risk of major bleeding and intracranial bleeding (adjusted hazard ratios, 0.66 and 0.4, respectively) and dabigatran was correlated with reduced risk of intracranial bleeding (adjusted hazard ratio, 0.45) among patients with atrial fibrillation.

Similar number of out-of-range next INR values for patients with, without extended testing interval